Article

Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial…

Case Reports in Cardiology · 2017 · Francesco Summaria, author Gregory A. Sgueglia, author Fabrizio D’Errico, author Antonella De Santis, author Fabiana Piccioni, author Gaetano Gioffrè, author Achille Gaspardone, author Nurten Sayar, Academic Editor

Key facts

Title Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
First author Francesco Summaria, author Gregory A. Sgueglia, author Fabrizio D’Errico, author Antonella De Santis, author Fabiana Piccioni, author Gaetano Gioffrè, author Achille Gaspardone, author Nurten Sayar, Academic Editor
Journal Case Reports in Cardiology
Published Dec 5, 2017
DOI 10.1155/2018/6503435
Devices mentioned K012777, K013272, K020806, K040425, K043228, K052503, K973616, K993353
Product codes mentioned CGS, JZO, KLS, LOJ, MMI, NBC

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature